ArticleAnalytical and bioanalytical chemistry2026
Machine learning-assisted SERS for rapid and accurate early screening of cervical cancer.
Article in Analytical and bioanalytical chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Early and accurate screening of cervical cancer (CC) is critical for improving patient prognosis and reducing mortality, and there is an urgent clinical demand for noninvasive, sensitive, and reliable detection methods. In this study, a serum detection platform based on surface-enhanced Raman scattering (SERS) was constructed, and a principal component analysis-multiple kernel support vector machine-grid search (PCA-MKSVM-GS) model was established to realize accurate and stable identification of cervical cancer patients. High-performance Ag nanocube arrays (AgNC arrays) were fabricated as SERS-active substrates to effectively acquire serum molecular fingerprint information. Serum SERS spectra were collected from cervical cancer patients and healthy subjects, and subsequently subjected to spectral preprocessing including noise reduction, baseline correction, and normalization. The preprocessed spectra were imported into the model, where PCA performed feature extraction and dimensionality reduction, MKSVM enhanced the nonlinear fitting ability for complex spectral features, and GS automatically optimized the hyperparameters of the model. The accuracy evaluation, feature visualization analysis, and ablation experiments verified that the proposed platform achieved good classification performance with an accuracy of 97.1%. Furthermore, key characteristic peaks for early cervical cancer were successfully captured from the loading plots. This method provided a noninvasive, feasible, and efficient spectral detection strategy for early clinical screening and auxiliary diagnosis of cervical cancer, and exhibited good application potential. It is expected to serve as a promising auxiliary tool for clinical translation of SERS-based cancer diagnosis.
Indexed as
Identifiers
42377457What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.